Prolyl hydroxylase inhibitors
US8557834B2 · kind B2 · utility
8Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2012 |
| Grant date | Oct 15, 2013 |
| Priority date | — |
| Expiry date | Nov 2, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I)which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.